Alphabet spinoff Isomorphic Labs reportedly raising funding at up to $50B valuation
SiliconANGLE

Isomorphic Labs, an Alphabet spinoff focused on AI-driven drug discovery, is reportedly raising funding at a valuation between $40 billion and $50 billion. Its AI platform IsoDDE excels at identifying binding pockets on disease-causing cells, outperforming competitors including AlphaFold, and has secured nearly $3 billion in partnerships with major pharmaceutical companies.
Full coverage from 2 sourcesAlphabet's Isomorphic Labs Seeks Funding Valuation Between $40B and $50BSee full coverage